Schwannomas are benign tumors of the peripheral nervous system which commonly occur in their solitary form in otherwise normal individuals. Rarely, individuals develop multiple schwannomas arising from one or many elements of the peripheral nervous system, either associated with the classic tumor suppressor gene syndrome neurofibromatosis 2 (NF2) or without vestibular nerve involvement (schwannomatosis). The hypothesis of this study is that schwannomatosis is a distinct clinical entity caused by genetic inactivation of a tumor suppressor gene. The steps proposed to investigate this hypothesis are: 1. Clinical characterization of a cohort of patients with schwannomatosis and related syndromes. 2. Molecular genetic analysis of the NF2 gene in tumorous and non tumorous tissues from these patients. 3. Microsatellite analysis to identify other possible loci for this syndrome. The goals of this project include a further understanding of the functioning of the NF2 tumor suppressor gene and the identification of other genes which may be involved in schwannoma formation. This information will not only be helpful to the understanding of NF2 and related disorders, but will also contribute to the rapidly expanding field of genetic causes of tumor formation, including the recognition of the role of atypical genetics such as somatic instability and mosaicism. This research plan will lay the framework for the establishment of schwannomatosis as a third major form of NF and lead to both improved clinical recognition and management and greater scientific understanding of the processes leading to NF.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS035878-03
Application #
6187818
Study Section
Special Emphasis Panel (ZRG1-NLS-1 (02))
Program Officer
Finkelstein, Robert
Project Start
1998-04-01
Project End
2002-03-31
Budget Start
2000-04-01
Budget End
2001-03-31
Support Year
3
Fiscal Year
2000
Total Cost
$169,093
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Kaufman, David L; Heinrich, Bianca S; Willett, Christine et al. (2003) Somatic instability of the NF2 gene in schwannomatosis. Arch Neurol 60:1317-20
Bashour, Anne-Marie; Meng, J-J; Ip, Wallace et al. (2002) The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells. Mol Cell Biol 22:1150-7
Blakley, P; Louis, D N; Short, M P et al. (2001) A clinical study of patients with multiple isolated neurofibromas. J Med Genet 38:485-8
Campen, R; Mankin, H; Louis, D N et al. (2001) Familial occurrence of adiposis dolorosa. J Am Acad Dermatol 44:132-6
MacCollin, M; Kwiatkowski, D (2001) Molecular genetic aspects of the phakomatoses: tuberous sclerosis complex and neurofibromatosis 1. Curr Opin Neurol 14:163-9